Human Genome Sciences Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 15.2 | 34.8 | 96.9 |
| Net Receivables | 24.9 | 38.7 | 64.5 |
| Inventories | -- | -- | -- |
| Other Current Assets | 28.0 | 99.6 | 230.6 |
| Total Current Assets | 68.2 | 173.1 | 392.0 |
| Net Fixed Assets | 259.3 | 268.8 | 285.2 |
| Other Noncurrent Assets | 346.7 | 507.2 | 472.4 |
| Total Assets | 674.2 | 949.1 | 1,149.7 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | -- | 52.8 | 37.0 |
| Short-Term Debt | -- | -- | 0.0 |
| Other Current Liabilities | 120.7 | 73.4 | 55.0 |
| Total Current Liabilities | 120.7 | 126.2 | 92.0 |
| Long-Term Debt | 756.5 | 754.1 | 751.5 |
| Other Noncurrent Liabilities | 38.4 | 80.7 | 92.3 |
| Total Liabilities | 915.5 | 961.0 | 935.7 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | (241.4) | (11.9) | 213.9 |
| Total Equity | (241.4) | (11.9) | 213.9 |
| Shares Outstanding (mil.) | 165.0 | 165.0 | 165.0 |
© 2009 Morningstar, Inc. Financial Data provided by
